JPS6225679B2 - - Google Patents

Info

Publication number
JPS6225679B2
JPS6225679B2 JP52025529A JP2552977A JPS6225679B2 JP S6225679 B2 JPS6225679 B2 JP S6225679B2 JP 52025529 A JP52025529 A JP 52025529A JP 2552977 A JP2552977 A JP 2552977A JP S6225679 B2 JPS6225679 B2 JP S6225679B2
Authority
JP
Japan
Prior art keywords
ester
deoxy
glucopyranosyl
alanyl
propionyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52025529A
Other languages
English (en)
Japanese (ja)
Other versions
JPS52139018A (en
Inventor
Odeibeeru Furansowaazu
Shedeido Rui
Rufuranshe Pieeru
Shoai Jan
Rudore Edogyaaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANBAARU AJANSU NASHIONARU DO BARORIZASHION DO RA RUSHERUSHU
Original Assignee
ANBAARU AJANSU NASHIONARU DO BARORIZASHION DO RA RUSHERUSHU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7606820A external-priority patent/FR2343483A1/fr
Priority claimed from FR7702646A external-priority patent/FR2369292A1/fr
Application filed by ANBAARU AJANSU NASHIONARU DO BARORIZASHION DO RA RUSHERUSHU filed Critical ANBAARU AJANSU NASHIONARU DO BARORIZASHION DO RA RUSHERUSHU
Publication of JPS52139018A publication Critical patent/JPS52139018A/ja
Publication of JPS6225679B2 publication Critical patent/JPS6225679B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2552977A 1976-03-10 1977-03-10 Immuno adjuvant and antiinfection adjuvant composed of mainly nnacetyll muramiccllalanyllddglutamic ester or nnacetyllmuramiccllalanylldd isoglutamic ester Granted JPS52139018A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7606820A FR2343483A1 (fr) 1976-03-10 1976-03-10 L'ester methylique de la 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-alanyl-d-isoglutamine et le diester methylique de l'acide 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-alanyl-d-glutamique et medicaments les contenant
FR7702646A FR2369292A1 (fr) 1976-11-02 1977-01-31 Agents adjuvants immunit

Publications (2)

Publication Number Publication Date
JPS52139018A JPS52139018A (en) 1977-11-19
JPS6225679B2 true JPS6225679B2 (enExample) 1987-06-04

Family

ID=26219340

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2552977A Granted JPS52139018A (en) 1976-03-10 1977-03-10 Immuno adjuvant and antiinfection adjuvant composed of mainly nnacetyll muramiccllalanyllddglutamic ester or nnacetyllmuramiccllalanylldd isoglutamic ester

Country Status (2)

Country Link
JP (1) JPS52139018A (enExample)
GB (1) GB1573126A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI66878C (fi) * 1978-02-24 1984-12-10 Ciba Geigy Ag Foerfarande foer framstaellning av nya antigenderivat
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
JPH0625067B2 (ja) * 1986-05-13 1994-04-06 全国農業協同組合連合会 子豚の離乳後下痢の感染防止法

Also Published As

Publication number Publication date
GB1573126A (en) 1980-08-13
JPS52139018A (en) 1977-11-19

Similar Documents

Publication Publication Date Title
US4153684A (en) Immunizing and anti-infectious adjuvant agents constituted by N-acetyl-muramyl-L-alanyl-D-glutamic acid derivatives
US4327085A (en) Biologically active compositions and methods of use
RU2160606C2 (ru) Мутант энтеротоксина, эффективный в качестве нетоксичного орального стимулятора
US4454121A (en) Synthetic peptides corresponding to antigenic determinants of the M protein of Streptococcus pyogenes
CN105085349B (zh) 与合成的β‑1,6 葡糖胺寡糖相关的方法和组合物
JPH06500772A (ja) 改良されたワクチン組成物
EP0003833B2 (de) Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
US4158052A (en) Oil-free adjuvant compositions containing N-acetyl-muramyl-L-alanyl-D-isoglutamine
Shimizu et al. Biological activities of lipopolysaccharide-like substance (LLS) extracted from Leptospira interrogans serovar canicola strain Moulton
GB2027716A (en) Oligomers of compounds of the muramylpeptide type and medicaments containing them
CA2257826A1 (en) Helicobacter pylori adhesin binding group antigen
JPS6225679B2 (enExample)
AU655425B2 (en) Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae
EP0006068B1 (fr) Composés du type muramyl-peptide et médicaments les contenant
US4242270A (en) Process for separating lipids from endotoxins
JPH01311093A (ja) 置換ｎ―グリコシルアミド類
US20240173394A1 (en) Immunogenic fusion protein
DE2710454C2 (de) Ester von N-Acetylmuramyl-L-alanyl-D-isoglutamin sowie Mono- und Diester von N-Acetylmuramyl-L-alanyl-D-glutaminsäure, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US4728639A (en) Type-specific opsonic antibodies evoked with a synthetic peptide of streptococcal M protein conjugated to polylysine without adjuvant
CA2218385A1 (en) Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins
CN114555629A (zh) 糖肽疫苗
EP4445910A1 (en) Vaccine composition for inducing anti-il-23 antibody
CA1060796A (en) Oil-free adjuvant composition containing muramyl dipeptide
KR830002059B1 (ko) 멀아밀-펲타이드형태인 신규 화합물의 제조방법
KR20150066794A (ko) 폐렴연쇄상구균 유래 막소포체를 포함하는 폐렴연쇄상구균 백신 조성물